CIBC Private Wealth Group
FENC icon

CIBC Private Wealth Group’s Fennec Pharmaceuticals FENC Stock Holding History

CIBC Private Wealth Group’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$12.1K Hold
1,565
– – ﹤0.01% 2354
2025
Q3 		$14.6K Hold
1,565
– – ﹤0.01% 2256
2025
Q2 		$13K Hold
1,565
– – ﹤0.01% 2171
2025
Q1 		$7.84K Hold
1,565
– – ﹤0.01% 2313
2024
Q4 		$9.52K Hold
1,565
– – ﹤0.01% 2287
2024
Q3 		$7.83K Hold
1,565
– – ﹤0.01% 2474
2024
Q2 		$9.09K Hold
1,565
– – ﹤0.01% 2330
2024
Q1 		$17K Buy
+1,565
New +$15.7K ﹤0.01% 2100

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIBC Private Wealth Group's FENC Position: Q4 2025 in Review

CIBC Private Wealth Group held its Fennec Pharmaceuticals (FENC) position steady in Q4 2025 at 1,565 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2354.

CIBC Private Wealth Group first reported a position in FENC in Q1 2024 and has held it in 8 quarters since. The position peaked at $17K in Q1 2024. 96 funds tracked by Wall St. Rank hold FENC as of Q4 2025.

  • CIBC Private Wealth Group held 1,565 shares of Fennec Pharmaceuticals worth $12.1K as of Q4 2025.
  • CIBC Private Wealth Group left its Fennec Pharmaceuticals share count unchanged in Q4 2025.
  • Fennec Pharmaceuticals made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2354 holding.
  • CIBC Private Wealth Group first reported a position in Fennec Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • CIBC Private Wealth Group's Fennec Pharmaceuticals position peaked at $17K in Q1 2024.
  • 96 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.